Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endarterectomy, Carotid | 11 | 2023 | 546 | 4.360 |
Why?
|
Peripheral Arterial Disease | 19 | 2024 | 1188 | 3.190 |
Why?
|
Carotid Stenosis | 8 | 2018 | 854 | 2.880 |
Why?
|
Stents | 11 | 2018 | 3280 | 1.700 |
Why?
|
Endovascular Procedures | 16 | 2024 | 1979 | 1.660 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2023 | 277 | 1.540 |
Why?
|
Ontario | 22 | 2021 | 383 | 1.510 |
Why?
|
Aortic Aneurysm, Abdominal | 13 | 2023 | 1186 | 1.350 |
Why?
|
Vascular Surgical Procedures | 8 | 2021 | 1475 | 1.270 |
Why?
|
Angioplasty | 3 | 2017 | 364 | 1.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 10 | 2023 | 1390 | 1.050 |
Why?
|
Carotid Arteries | 2 | 2018 | 952 | 0.870 |
Why?
|
Aortic Rupture | 4 | 2020 | 310 | 0.800 |
Why?
|
Diabetic Foot | 3 | 2021 | 355 | 0.800 |
Why?
|
Diabetic Angiopathies | 3 | 2021 | 818 | 0.740 |
Why?
|
Forearm | 1 | 2023 | 409 | 0.740 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2019 | 686 | 0.730 |
Why?
|
Diabetes Mellitus | 6 | 2022 | 5751 | 0.720 |
Why?
|
Arteriovenous Fistula | 2 | 2022 | 315 | 0.710 |
Why?
|
Fibrinolytic Agents | 2 | 2018 | 2158 | 0.630 |
Why?
|
Leg | 2 | 2020 | 1116 | 0.610 |
Why?
|
Stroke | 9 | 2023 | 9981 | 0.580 |
Why?
|
Clinical Coding | 2 | 2021 | 171 | 0.550 |
Why?
|
Blood Coagulation | 2 | 2020 | 1127 | 0.530 |
Why?
|
Angioplasty, Balloon | 2 | 2020 | 653 | 0.530 |
Why?
|
Graft Occlusion, Vascular | 3 | 2023 | 549 | 0.490 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2021 | 941 | 0.480 |
Why?
|
Carotid Artery Diseases | 2 | 2018 | 882 | 0.480 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2015 | 85 | 0.480 |
Why?
|
Aneurysm, Infected | 1 | 2014 | 85 | 0.470 |
Why?
|
Canada | 10 | 2022 | 2065 | 0.470 |
Why?
|
Popliteal Artery | 1 | 2015 | 317 | 0.450 |
Why?
|
Risk Reduction Behavior | 2 | 2016 | 1125 | 0.440 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 238 | 0.440 |
Why?
|
Intracranial Hemorrhages | 1 | 2018 | 855 | 0.440 |
Why?
|
Aneurysm, False | 2 | 2015 | 276 | 0.430 |
Why?
|
Specialization | 1 | 2017 | 777 | 0.420 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2022 | 3068 | 0.420 |
Why?
|
Databases, Factual | 8 | 2020 | 7729 | 0.420 |
Why?
|
Vascular Patency | 3 | 2023 | 886 | 0.400 |
Why?
|
Femoral Artery | 1 | 2015 | 845 | 0.390 |
Why?
|
Myocardial Infarction | 5 | 2023 | 11727 | 0.370 |
Why?
|
Treatment Outcome | 23 | 2024 | 63114 | 0.350 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3255 | 0.330 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2019 | 9959 | 0.330 |
Why?
|
Paclitaxel | 1 | 2015 | 1708 | 0.320 |
Why?
|
Bacteremia | 1 | 2014 | 962 | 0.300 |
Why?
|
Risk Factors | 21 | 2024 | 72290 | 0.270 |
Why?
|
Humans | 65 | 2024 | 744343 | 0.260 |
Why?
|
Staphylococcal Infections | 1 | 2014 | 1400 | 0.260 |
Why?
|
Retrospective Studies | 22 | 2024 | 77449 | 0.250 |
Why?
|
Embolization, Therapeutic | 1 | 2014 | 1392 | 0.250 |
Why?
|
Male | 36 | 2023 | 350118 | 0.240 |
Why?
|
Vascular System Injuries | 2 | 2019 | 250 | 0.230 |
Why?
|
Home Care Services | 2 | 2021 | 606 | 0.230 |
Why?
|
Renal Dialysis | 2 | 2023 | 1786 | 0.230 |
Why?
|
Female | 34 | 2023 | 380194 | 0.210 |
Why?
|
Time Factors | 11 | 2022 | 40075 | 0.200 |
Why?
|
Middle Aged | 23 | 2023 | 213383 | 0.200 |
Why?
|
Aged | 22 | 2021 | 163280 | 0.200 |
Why?
|
Aged, 80 and over | 13 | 2021 | 57776 | 0.200 |
Why?
|
Brachial Artery | 1 | 2023 | 369 | 0.200 |
Why?
|
Intermittent Claudication | 2 | 2022 | 309 | 0.200 |
Why?
|
Postoperative Complications | 7 | 2022 | 15295 | 0.200 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7279 | 0.190 |
Why?
|
Radial Artery | 1 | 2022 | 194 | 0.190 |
Why?
|
Extremities | 2 | 2016 | 865 | 0.190 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2017 | 1518 | 0.180 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2019 | 63 | 0.170 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2019 | 3923 | 0.170 |
Why?
|
Lithotripsy | 1 | 2019 | 143 | 0.160 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6489 | 0.160 |
Why?
|
Anesthesia, Epidural | 1 | 2020 | 228 | 0.150 |
Why?
|
Lower Extremity | 2 | 2024 | 1158 | 0.150 |
Why?
|
Anesthesia, Spinal | 1 | 2020 | 269 | 0.150 |
Why?
|
Personnel Turnover | 1 | 2017 | 83 | 0.140 |
Why?
|
Health Care Surveys | 2 | 2021 | 2453 | 0.140 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1411 | 0.140 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 550 | 0.130 |
Why?
|
Odds Ratio | 3 | 2017 | 9849 | 0.130 |
Why?
|
Workload | 1 | 2021 | 850 | 0.130 |
Why?
|
Ischemia | 2 | 2024 | 1907 | 0.130 |
Why?
|
Propensity Score | 2 | 2019 | 1781 | 0.130 |
Why?
|
Indians, North American | 1 | 2018 | 355 | 0.130 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15165 | 0.120 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 451 | 0.120 |
Why?
|
Patient Readmission | 2 | 2019 | 3114 | 0.120 |
Why?
|
Arabs | 1 | 2016 | 178 | 0.120 |
Why?
|
Cross-Sectional Studies | 7 | 2021 | 25043 | 0.120 |
Why?
|
Hypolipidemic Agents | 1 | 2019 | 604 | 0.120 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12354 | 0.120 |
Why?
|
Hospital Costs | 1 | 2020 | 985 | 0.120 |
Why?
|
Aneurysm, Ruptured | 1 | 2018 | 452 | 0.110 |
Why?
|
Drug-Eluting Stents | 1 | 2020 | 753 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 804 | 0.110 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3508 | 0.110 |
Why?
|
Renin-Angiotensin System | 1 | 2017 | 759 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.110 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1082 | 0.110 |
Why?
|
Coronary Stenosis | 1 | 2019 | 834 | 0.110 |
Why?
|
Aortography | 1 | 2014 | 437 | 0.110 |
Why?
|
Benchmarking | 1 | 2019 | 1042 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2020 | 1171 | 0.110 |
Why?
|
Wounds, Nonpenetrating | 1 | 2019 | 794 | 0.110 |
Why?
|
Patient Admission | 1 | 2020 | 1380 | 0.110 |
Why?
|
Aneurysm | 1 | 2015 | 339 | 0.100 |
Why?
|
Foot | 1 | 2015 | 527 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2019 | 849 | 0.100 |
Why?
|
Hospitalization | 3 | 2021 | 10262 | 0.100 |
Why?
|
Risk Assessment | 7 | 2023 | 23338 | 0.100 |
Why?
|
Perioperative Care | 1 | 2018 | 1002 | 0.100 |
Why?
|
Cost of Illness | 1 | 2020 | 1859 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2376 | 0.090 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 1008 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2019 | 2289 | 0.090 |
Why?
|
Blood Vessel Prosthesis | 1 | 2014 | 933 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7659 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2046 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2291 | 0.080 |
Why?
|
Internship and Residency | 2 | 2021 | 5788 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2616 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2518 | 0.080 |
Why?
|
Boston | 1 | 2021 | 9313 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2023 | 3445 | 0.070 |
Why?
|
Patient Selection | 1 | 2019 | 4215 | 0.070 |
Why?
|
International Classification of Diseases | 2 | 2023 | 867 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.070 |
Why?
|
Mortality | 1 | 2018 | 2864 | 0.070 |
Why?
|
Cholesterol, LDL | 1 | 2016 | 2356 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3022 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1797 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 2872 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3313 | 0.070 |
Why?
|
Logistic Models | 2 | 2019 | 13408 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3461 | 0.070 |
Why?
|
Students, Medical | 1 | 2019 | 1862 | 0.070 |
Why?
|
Health Care Costs | 1 | 2019 | 3209 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2266 | 0.070 |
Why?
|
Registries | 1 | 2021 | 8089 | 0.070 |
Why?
|
General Surgery | 1 | 2017 | 1636 | 0.070 |
Why?
|
Specialties, Surgical | 2 | 2021 | 391 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3843 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 3712 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2016 | 2071 | 0.060 |
Why?
|
Adult | 9 | 2021 | 214055 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12245 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39050 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3158 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2020 | 21746 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2016 | 3265 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7913 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6256 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20129 | 0.050 |
Why?
|
Limb Salvage | 1 | 2024 | 433 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 12804 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2019 | 2539 | 0.050 |
Why?
|
Blood Pressure | 1 | 2016 | 8554 | 0.050 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.050 |
Why?
|
Anesthetics, Combined | 1 | 2020 | 40 | 0.050 |
Why?
|
Ecology | 1 | 2020 | 106 | 0.050 |
Why?
|
Cohort Studies | 1 | 2023 | 40561 | 0.050 |
Why?
|
Antithrombin III | 1 | 2020 | 128 | 0.040 |
Why?
|
Prothrombin | 1 | 2020 | 185 | 0.040 |
Why?
|
Nursing Services | 1 | 2019 | 8 | 0.040 |
Why?
|
Educational Status | 2 | 2019 | 2540 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6487 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 11725 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8480 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12720 | 0.040 |
Why?
|
Blood Coagulation Factors | 1 | 2020 | 355 | 0.040 |
Why?
|
New York | 1 | 2020 | 886 | 0.040 |
Why?
|
Retreatment | 1 | 2019 | 610 | 0.040 |
Why?
|
Societies, Medical | 2 | 2019 | 3743 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2020 | 634 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1107 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2019 | 1014 | 0.030 |
Why?
|
Saudi Arabia | 1 | 2016 | 209 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1769 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6309 | 0.030 |
Why?
|
Ligation | 1 | 2015 | 453 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12788 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1681 | 0.030 |
Why?
|
Universities | 1 | 2019 | 956 | 0.030 |
Why?
|
Sex Factors | 2 | 2017 | 10397 | 0.030 |
Why?
|
Disease Progression | 2 | 2019 | 13284 | 0.030 |
Why?
|
Educational Measurement | 1 | 2019 | 1210 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2020 | 1889 | 0.020 |
Why?
|
Career Choice | 1 | 2017 | 744 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2716 | 0.020 |
Why?
|
Perception | 1 | 2016 | 1198 | 0.020 |
Why?
|
Reoperation | 1 | 2019 | 4201 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6538 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5097 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29063 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2023 | 15076 | 0.020 |
Why?
|
Pilot Projects | 1 | 2020 | 8324 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4468 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Curriculum | 1 | 2019 | 3605 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3952 | 0.020 |
Why?
|
Life Style | 1 | 2017 | 3835 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9146 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
Quality Improvement | 1 | 2019 | 3749 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13881 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 56430 | 0.010 |
Why?
|
Adolescent | 1 | 2015 | 85781 | 0.000 |
Why?
|
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_